| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/19/1996 | WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 09/19/1996 | WO1996028156A1 Novel benzothiophene compounds and methods |
| 09/19/1996 | WO1996021463A3 New applications of lysozyme dimer |
| 09/19/1996 | CA2214999A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes |
| 09/19/1996 | CA2214850A1 Novel benzothiophene compounds and methods |
| 09/19/1996 | CA2214490A1 Method for treatment of autoimmune diseases using interferon-tau |
| 09/18/1996 | EP0732331A1 Novel benzothiophene compounds and methods for inhibiting lipoxygenase and leukotrienes |
| 09/18/1996 | EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals |
| 09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 09/18/1996 | EP0731811A1 Chaperonin 10 |
| 09/18/1996 | EP0731791A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 09/18/1996 | EP0731790A1 Tachykinin antagonists |
| 09/18/1996 | EP0731789A1 Dp-iv-serine protease inhibitors |
| 09/18/1996 | EP0731697A1 Ssi tyrphostins and pharmaceutical compositions |
| 09/18/1996 | EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/18/1996 | CN1131420A Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 09/18/1996 | CN1131041A Soft gelatin pharmaceutical dosage form |
| 09/17/1996 | US5556862 Pharmaceutical compositions containing isoquinoline derivatives |
| 09/17/1996 | US5556855 N-heterocyclic substituted salicylic acids |
| 09/17/1996 | US5556845 11-β substituted-19-nor steroids |
| 09/17/1996 | US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c |
| 09/17/1996 | US5556785 Lactobacillus used to enhance immunological functions |
| 09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
| 09/17/1996 | US5556644 Nutritional supplement for the elderly |
| 09/12/1996 | WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 09/12/1996 | WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/12/1996 | WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives |
| 09/12/1996 | WO1996027390A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 09/12/1996 | WO1996027381A1 Immunosuppressive agents |
| 09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/11/1996 | EP0731108A1 Method of manufacturing a therapeutic agent for the regeneration of oligodendrocytes |
| 09/11/1996 | EP0731099A1 N-(3-benzofuranyl)urea-derivatives |
| 09/11/1996 | EP0731088A2 Retroviral protease inhibitors |
| 09/11/1996 | EP0730864A1 Medicament for treating cardiac inflammatory disease |
| 09/11/1996 | EP0730609A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 09/11/1996 | EP0730608A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| 09/11/1996 | EP0730598A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 09/11/1996 | EP0730597A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 09/11/1996 | EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 09/11/1996 | EP0730587A1 3-aryl-2-isoxazolines as antiinflammatory agents |
| 09/11/1996 | EP0730579A1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 09/11/1996 | EP0730578A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s) |
| 09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
| 09/11/1996 | EP0507861B1 Diaromatic substituted anti-aids compounds |
| 09/11/1996 | EP0484395B1 Method of preventing graft rejection in solid organ transplantation |
| 09/11/1996 | CN1130906A Oxathiolanes, method for their preparation and pharmaceutical compositions containing same |
| 09/11/1996 | CN1130905A Process for making HIV protease inhibitors |
| 09/11/1996 | CN1130898A Difluoro statone antiviral analogs |
| 09/11/1996 | CN1130873A Method of treating HIV with azaspiranes |
| 09/11/1996 | CN1130871A Method of inhibiting replication of human immunodeficiency viruses with substituted azaspiranes |
| 09/11/1996 | CN1032754C Process for preparing immunostimulating 6-aryl-5,6-dihydroimidazo |2,1-b¨ thiazole derivatives |
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554653 Inhibitors of HIV protease useful for the treatment of AIDS |
| 09/10/1996 | US5554642 Arylalkyl(thio) amides |
| 09/10/1996 | US5554641 Nonpeptides as tachykinin antagonists |
| 09/10/1996 | US5554612 Immunosuppressants, viricides, antitumor and antiinflammatory agents |
| 09/10/1996 | US5554599 22-thio vitamin D derivatives |
| 09/10/1996 | US5554538 DNA sequences derived from papillomavirus HPV-33 genome |
| 09/10/1996 | US5554384 High dose formulations of mycophenolate mofetil and mycophenolic acid |
| 09/10/1996 | CA2170818A1 Method of treating cardiac inflammatory disease |
| 09/07/1996 | CA2170824A1 N-(3-benzofuranyl)urea-derivatives |
| 09/06/1996 | WO1996027018A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
| 09/06/1996 | WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996026734A1 Antiviral combinations of bch-189 and ritonavir |
| 09/06/1996 | WO1996026726A1 Pharmaceutical composition for piperidinoalkanol compounds |
| 09/06/1996 | WO1996026725A1 Method for treating atopic dermatitis and contact dermatitis |
| 09/06/1996 | WO1996021015A3 Combination gene delivery vehicles |
| 09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 09/06/1996 | WO1996020690A3 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds |
| 09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 09/06/1996 | WO1996018646A3 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
| 09/06/1996 | CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | CA2213734A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
| 09/06/1996 | CA2213621A1 Antiviral combinations of bch-189 and ritonavir |
| 09/04/1996 | EP0729473A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 09/04/1996 | EP0729471A1 Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| 09/04/1996 | EP0729467A1 Prodrugs of an inhibitor of hiv protease |
| 09/04/1996 | EP0729459A1 Phenyl-alkyl imidazoles as h3-receptor antagonists |
| 09/04/1996 | EP0729361A1 Method of treating neurological disorders |
| 09/04/1996 | EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases |
| 09/04/1996 | EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 09/04/1996 | EP0636031B1 Vaccine adjuvant |
| 09/04/1996 | EP0630384A4 Methods and compounds for prevention of graft rejection. |
| 09/04/1996 | EP0589924B1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 09/04/1996 | CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them |
| 09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
| 09/03/1996 | US5552521 Process for preparing certain aza cyclohexapeptides |
| 09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
| 09/03/1996 | US5552439 Aminophenol derivatives |